To
enhance the bioavailability of poorly soluble therapeutics,
enabling formulations that generate supersaturation are currently
of great interest. There is limited knowledge of how the gastrointestinal
environment can influence the complex phase behavior of these systems,
in particular, crystallization. Simulated media are generally used
to mimic physiologically relevant fluids, although their predictability
remains unknown for crystallizing systems since they are simplified
models of the gastrointestinal fluids. The purpose of this study was
to evaluate and compare how different simulated media, as well as
aspirated intestinal fluid, impact the phase behavior of supersaturated
solutions of two poorly soluble compounds, atazanavir and posaconazole,
in fasted-state conditions. The onset of nucleation and progression
of crystallization were found to be highly medium dependent. In the
aspirated fluid, the crystallization kinetics for both compounds was
significantly reduced compared to commercial simulated media. The
use of simple buffers or current simulated fluids as surrogates for
intestinal fluids appears to require further verification when attempting
to predict crystallization kinetics of supersaturated solutions, based
on the observed lack of correlation between commercial media and human
fluids. The findings highlight the importance of carefully considering
the composition of in vitro testing media for assessing
crystallization kinetics, particularly in the context of supersaturating
formulations.